<DOC>
	<DOCNO>NCT00910923</DOCNO>
	<brief_summary>This single center study conduct two part . Part 1 ass safety , tolerability , pharmacokinetics , pharmacodynamics single ascend dos JNJ-38431055 healthy male volunteer . Part 2 assess effect food pharmacokinetics JNJ-38431055 .</brief_summary>
	<brief_title>A Study Evaluate Safety , Tolerability , Pharmacokinetics , Pharmacodynamics JNJ-38431055 Healthy Male Volunteers</brief_title>
	<detailed_description>The study include 2 Parts conduct single center . Part 1 randomize ( study drug assign chance ) , double-blind ( neither volunteer investigator know name assign study drug ) , placebo-controlled ( placebo substance look JNJ-38431055 contains JNJ-38431055 ) , single ascend dose study . In Part 1 , study drug ( i.e. , JNJ-38431055 placebo ) administer orally single dos Day 1 three treatment period . In Part 1 , volunteer , study consist screen evaluation visit , 3 period double-blind treatment , final , follow-up examination . The total study duration volunteer approximately 9 week . Part 2 randomized , open-label , 2-period crossover study evaluate effect administer JNJ-38431055 together food pharmacokinetics JNJ-38431055 , compare administration fast condition . In Part 2 , study drug ( JNJ-38431055 administer orally single dos Day 1 two treatment period . There least 7 day dos . In Part 1 , study drug ( i.e. , JNJ-38431055 placebo ) administer orally single dos Day 1 three treatment period . In Part 2 , study drug ( JNJ-38431055 ) administer orally single dos Day 1 two treatment period .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Body Mass Index ( BMI ) 18.5 29.9 kg/m2 ( inclusive ) Healthy basis physical examination include medical history , vital sign , 12lead ECG , screen lab test perform Volunteers must sign informed consent document indicate understand purpose procedure require study willing participate study History , currently active , illness medical condition disorder Investigator consider clinically significant Smoker tobacco user within past 6 month History recent major surgery ( within 6 month study start ) Positive test alcohol and/or drug abuse Psychological and/or emotional problem , would render informed consent invalid , limit ability volunteer comply study requirement Any condition , opinion investigator , would compromise well volunteer study prevent volunteer meeting perform study requirement .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Diabetes Mellitus , Type 2</keyword>
</DOC>